0
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Of mice and men: a curious tale of disappearing plaques and tumbling stocks

Pages 1-4 | Published online: 01 Sep 2009
 

Abstract

Objective: To describe the events surrounding the recent termination of Elan Pharmaceutical's phase 2a trial of beta amyloid immunisation for Alzheimer's disease.

Conclusions: Excessive and uncritical enthusiasm for new treatments can lead to negative clinical and financial outcomes.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.